Results for tag: "Meconium Aspiration Syndrome Drug"

Meconium Aspiration Syndrome (MAS) is a condition that occurs when a newborn baby inhales meconium, the first stool passed by a newborn. It is a serious condition that can lead to respiratory distress, pneumonia, and even death. Treatment for MAS typically involves the use of respiratory drugs, such as bronchodilators, antibiotics, and corticosteroids. These drugs are used to reduce inflammation, open the airways, and reduce the risk of infection. In some cases, mechanical ventilation may be necessary to help the baby breathe. The MAS drug market is composed of a variety of companies that specialize in the development and manufacture of respiratory drugs. These companies include GlaxoSmithKline, Merck & Co., Pfizer, AstraZeneca, and Novartis. These companies are dedicated to providing safe and effective treatments for MAS and other respiratory conditions. Show Less Read more